
Zexonat S 1000mg/250mg Injection
Marketer
Osnat Pharmaceuticals
Salt Composition
Cefoperazone (1000mg) + Sulbactam (250mg)
Overview Zexonat S 1000mg/250mg Injection
Combiflox, a 1000mg/250mg injectable formulation, combats diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curtailing infection spread. Administration must be strictly under medical guidance. Complete the prescribed dosage; premature cessation may compromise efficacy. Regular appointments are crucial. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Seek immediate help for allergic reactions (rash, itching, swelling, dyspnea). Inform your physician of all concurrent medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration are vital for optimal recovery. Your physician may order tests to monitor therapeutic response.
Primary Ingredients of Zexonat S 1000mg/250mg Injection
No text provided to rephrase.
Uses of Zexonat S 1000mg/250mg Injection
Combating Bacterial Infections
Major Benefits of Zexonat S 1000mg/250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Zexonat S 1000mg/250mg Injection:
- Decreased white blood cell count (neutrophils)
- Decreased white blood cell count (lymphocytes)
- Decreased hemoglobin
- Decreased hematocrit level
- Low blood platelets
- Coagulation disorder
- Increased white blood cell count (eosinophils)
- Diarrhea
- Nausea
- Increased alanine aminotransferase
- Increased aspartate aminotransferase
- Increased alkaline phosphatase level in blood
- Vomiting
- Increased bilirubin in the blood
How to use Zexonat S 1000mg/250mg Injection:
This medication will be administered by your physician or their qualified nurse; self-medication is strongly discouraged.
How Zexonat S 1000mg/250mg Injection works:
Zexonat S 1000mg/250mg injection combines Cefoperazone, an antibiotic, with Sulbactam, a beta-lactamase inhibitor. Cefoperazone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thereby boosting Cefoperazone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholUNSAFE
Ingestion of alcohol during Zexonat S 1000mg/250mg Injection treatment may result in adverse effects including facial redness, tachycardia, queasiness, dehydration, thoracic pain, and hypotension (a disulfiram-like reaction).
PregnancySAFE IF PRESCRIBED
The injectable medication Zexonat S (1000mg/250mg) is typically regarded as safe for use during pregnancy. Preclinical trials using animal models revealed minimal to no negative impacts on fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Zexonat S (1000mg/250mg) is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Zexonat S 1000mg/250mg Injection on driving ability is unknown. Refrain from driving if you develop symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Zexonat S 1000mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Zexonat S 1000mg/250mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Zexonat S 1000mg/250mg Injection :
Should you forget a scheduled Zexonat S 1000mg/250mg Injection, seek medical advice.
Facts to Know About Zexonat S 1000mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
